Federated Hermes, Inc. Bolt Biotherapeutics, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.98 - $1.46 $2,070 - $3,084	-2,113 Reduced 64.54%	1,161 $1,000
Q2 2023 Aug 14, 2023	SELL	$1.27 - $1.95 $590 - $906	-465 Reduced 12.44%	3,274 $4,000
Q1 2023 May 08, 2023	SELL	$1.29 - $1.66 $374 - $481	-290 Reduced 7.2%	3,739 $5,000
Q4 2022 Feb 13, 2023	BUY	$1.26 - $1.51 $2,376 - $2,847	1,886 Added 88.01%	4,029 $5,000
Q3 2022 Nov 14, 2022	BUY	$1.48 - $2.61 $3,171 - $5,593	2,143 New	2,143 $3,000

23M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $23.3M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.